• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23874 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     Institute for Clinical and Economic Review (ICER) Treatments for anemia in chronic kidney disease: effectiveness and value
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for ankyloglossia and ankyloglossia with concomitant lip-tie
2017     Agency for Healthcare Research and Quality (AHRQ) Treatments for basal cell and squamous cell carcinoma of the skin
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treatments for benign prostatic hypertrophy
2008     HAYES, Inc. Treatments for binge eating disorder
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for constipation: a review of systematic reviews
2018     NIHR Health Technology Assessment programme Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
2000     NIHR Health Technology Assessment programme Treatments for fatigue in multiple sclerosis: a rapid and systematic review
2016     Agency for Healthcare Research and Quality (AHRQ) Treatments for fecal incontinence
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for Fibromyalgia in Adult Subgroups
2016     NIHR Health Technology Assessment programme Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
2011     Agency for Healthcare Research and Quality (AHRQ) Treatments for localized prostate cancer: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation.
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2010     VA Technology Assessment Program (VATAP) Treatments for metastatic castrate-resistant prostate cancer
2004     Quality Improvement Scotland (NHS QIS ) Treatments for opiate dependence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for patients with genotype 1 chronic hepatitis C: a review of evidence-based guidelines
2023     Norwegian Institute of Public Health (NIPH) Treatments for relapsing and/or refractory multiple myeloma. A health technology assessment
2013     Agency for Healthcare Research and Quality (AHRQ) Treatments for seasonal allergic rhinitis
2003     NIHR Health Technology Assessment programme Treatments for spasticity and pain in multiple sclerosis: a systematic review
2021     Agency for Healthcare Research and Quality (AHRQ) Treatments, technologies, and models for management of acute and chronic pain in people with a history of substance use disorder
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2009     HAYES, Inc. Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Tremelimumab for unresectable pleural or peritoneal malignant mesothelioma – second and third line
2023     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Trends in utilisation of ultrasound by older Australians (2010-2019)
2024     National Institute for Health and Care Excellence (NICE) Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal). NICE technology appraisal guidance 945
2020     National Institute for Health and Care Excellence (NICE) Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant. NICE technology appraisal guidance 640
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treprostinil
2015     University of York Triage and minimising crowding in emergency departments
2018     The Regional Health Technology Assessment Centre (HTA-centrum) Triage for prioritisation in the emergency department
2010     The Swedish Council on Health Technology Assessment (SBU) Triage methods and patient flow processes at emergency departments
2021     Penn Medicine Center for Evidence-based Practice (CEP) Triaging COVID-19 in the emergency department
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2019     NIHR Health Technology Assessment programme Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2013     HAYES, Inc. Triangle tilt surgery for treatment of obstetric brachial plexus injury
2024     Agency for Care Effectiveness (ACE) Tricuspid transcatheter edge-to-edge repair system for symptomatic severe tricuspid regurgitation
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tricyclic antidepressants, clonidine, venlafaxine, and modafinil for the treatment of attention-deficit/hyperactivity disorder in adults: a review of the clinical evidence
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Tridimensional radiotherapy for breast cancer
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Trientine tetrahydrochloride (Cuprior®) [for] the treatment of Wilson's disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Trientine for treatment of Wilson's disease: clinical and cost-effectiveness, and safety
2009     HAYES, Inc. TriFlange acetabular prosthesis for failed total hip arthroplasty with massive acetabular defects
2016     HAYES, Inc. Trifluridine-tipiracil (Lonsurf) for refractory metastatic colorectal cancer
2016     National Institute for Health and Care Excellence (NICE) Trifluridine-tipiracil for previously treated metastatic colorectal cancer. NICE technology appraisal guidance 405
2024     National Institute for Health and Care Excellence (NICE) Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments. NICE technology appraisal guidance 1008
2022     National Institute for Health and Care Excellence (NICE) Trifluridinetipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments. NICE technology appraisal guidance 852
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Trigeminal nerve stimulation to treat neuralgia
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for chronic non-malignant musculoskeletal pain
2009     HAYES, Inc. Trigger point injections for myofascial pain
2013     HAYES, Inc. Trigger point injections for myofascial pain
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for non-malignant chronic pain
2010     Adelaide Health Technology Assessment (AHTA) Triggerfish continuous intraocular pressure monitoring system for the improved management of glaucoma patients
2024     Swiss Federal Office of Public Health (FOPH) Trikafta® for the treatment of patients with cystic fibrosis: an exploratory economic evaluation
2022     Swiss Federal Office of Public Health (FOPH) Trimonthly vs. monthly use of bone-targeted agents in patients with bone metastases and multiple myeloma
2021     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Triphasic biomaterial for augmentation of the osteoporotic femoral neck
2021     Austrian Institute for Health Technology Assessment (AIHTA) Triphasic biomaterial for augmentation of the osteoporotic femoral neck: systematic review
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Triple therapy for COPD
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2018     NIHR Health Technology Assessment programme Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2019     Penn Medicine Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2000     British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2011     HAYES, Inc. Trofile™ HIV tropism assay
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Troglitazone for Type II diabetes
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) TruScan
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2010     HAYES, Inc. Tuberous Sclerosis Complex (TSC; Bourneville Disease)
2022     National Institute for Health and Care Excellence (NICE) Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies. NICE technology appraisal guidance 786
2002     Health Technology Advisory Committee (HTAC) Tumescent liposuction
2001     HAYES, Inc. Tumescent liposuction
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2024     Swiss Federal Office of Public Health (FOPH) Tumor treating fields (TTFields) therapy for patients with glioblastoma multiforme
2003     The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Economic efficiency
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2024     National Institute for Health and Care Excellence (NICE) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. NICE diagnostics guidance 58
2023     Scottish Health Technologies Group (SHTG) Tumour profiling tests to guide chemotherapy decisions in early breast cancer
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2022     National Institute for Health and Care Excellence (NICE) Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. NICE interventional procedures guidance 746
2024     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Tunstall TSP – a system for receiving and processing personal alarm alerts
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2022     Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2006     University HealthSystem Consortium (UHC) Tygacil
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment
2024     NIHR Health and Social Care Delivery Program Types and aspects of support that young carers need and value, and barriers and enablers to access: the REBIAS-YC qualitative study
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2014     Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating ALK mutation-positive advanced non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating MET mutation-positive metastatic non-small-cell lung cancer